Inspecs Group Faces Multiple Takeover Approaches Amid Growing Consolidation in the Optical Sector

UK-listed manufacturer and supplier Inspecs Group plc (“Inspecs”) has confirmed it has received multiple unsolicited proposals, while Italian eyewear giant Safilo Group S.p.A. (“Safilo”) has separately submitted a non-binding offer for two of Inspecs’ business units.

On 23 October 2025, Inspecs issued a regulatory announcement under the UK’s City Code on Takeovers and Mergers (the “Code”), confirming it had received two separate unsolicited proposals: one from H2 Equity Partners Ltd. (“H2”), and another from a consortium comprising Risk Capital Partners and industry veteran Ian Livingstone (the “Consortium”). Each proposal contemplates a potential cash offer alongside the possibility of an alternative offer involving unlisted securities, to acquire the entire issued and to-be-issued share capital of Inspecs.

At the same time, Inspecs confirmed that on 21 October it had received a separate proposal from Safilo to acquire the group’s two divisions: the Eschenbach Group (global low-vision optics and premium eyewear supplier) and BoDe GmbH (German premium eyewear distributor).

Inspecs emphasised that there is no certainty that any firm offers will be made, nor as to the terms of any such offers, should they proceed.

Under Rule 2.6(a) of the Code, H2 and the Consortium have until 5:00 pm (London time) on 20 November 2025 to either announce a firm intention to make an offer under Rule 2.7 of the Code, or to announce they do not intend to make an offer—in which case the announcement will be treated under Rule 2.8.

On 24 October 2025, Safilo issued its own press note, confirming it had submitted a non-binding offer to acquire Inspecs’ Eschenbach and BoDe businesses, as part of its strategy to explore new investment opportunities. The note reiterated that “at present, there is no certainty regarding the outcome of any such offer.”

The approach indicates Safilo is selectively seeking to bolster its optics and premium-frames portfolios, rather than a full takeover of Inspecs. Industry commentary highlights that this element of the interest may reflect Safilo’s targeted growth strategy for niche/high-value segments.

For the B2B optical market, these developments are significant:

• Inspecs is a major global player in designing, manufacturing and distributing eyewear frames and components in-house for a broad retail and wholesale network. An offer for the entire business would reshape supply-chain dynamics.
• Safilo’s asset-level interest (Eschenbach and BoDe) suggests that larger eyewear manufacturers are actively consolidating mid-market suppliers and special-purpose units (low-vision, premium frames, niche distribution) to capture margin and scale.
• The appearance of private equity interest (H2, Risk Capital Partners) signals the increasing attractiveness of the eyewear manufacturing and supply model to financial investors—especially given secular trends in global eyewear demand and manufacturing rationalisation.
• For optical retailers and eyecare customers in Australia and Asia-Pacific, further consolidation among suppliers could impact lead-times, product diversity and distribution terms. Those downstream stakeholders may want to monitor developments closely.

At this stage, the key event to watch is whether H2 or the Consortium will announce a firm intention by the 20 November deadline to proceed with a full takeover of Inspecs. Absent such announcement, Inspecs may focus instead on the Safilo transaction or other strategic options.

If an offer is made—and depending on its valuation terms—the successful bidder could gain control of a significant global manufacturing network and supplier portfolio. For local Australian and APAC markets, this might translate into changes in sourcing strategy, consolidation of suppliers and potentially shifting product-service propositions for optical chains.

The twin announcements from Inspecs and Safilo reflect a moment of potential transformation in the global eyewear supply chain. Whether via a full corporate takeover or targeted acquisition of key subsidiaries, the drive to scale, capture margin and diversify into higher value segments appears to be accelerating. Optical industry stakeholders—including Australian wholesalers, retailers and labs—should stay alert to how this may impact supply-chain structure, vendor relationships and innovation pipelines in the months ahead.